![](https://d3ilqtpdwi981i.cloudfront.net/0WN83bnMb1DBwv3bRuEG-lfjk40=/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/28/05/54/28055424-ee93-4870-80e6-bfefe83aae07/thumbnail_7c0261e0-62ca-4770-977e-43c9d370b0c5.jpg)
Article
Response to "Pervasive Sequence Patents Cover the Entire Human Genome"
All Faculty Scholarship
Document Type
Article
Publication Date
1-1-2014
Disciplines
Abstract
In a widely reported article by Jeffrey Rosenfeld and Christopher Mason published in Genome Medicine, significant misstatements were made, because the authors did not sufficiently review the claims – which define the legal scope of a patent – in the patents they analyzed. Specifically, the authors do not provide an adequate basis for their assertion that 41% of the genes in the human genome have been claimed.
Citation Information
Response to "Pervasive Sequence Patents Cover the Entire Human Genome," 6 Genome Med. 14 (2014) (co-authored)